Edwards Lifesciences Corp (EW)

Sector: Healthcare
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country: United States
Exchange: NYSE
Market cap: $59.73B
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Latest financial period: September 30, 2026
Filed with the SEC: November 4, 2026
Estimated earnings date: Not available
Profit #626 of 1422 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROE/ROA | 56.7% | 82.2% | 84.3% | 85.0% |
Growth #199 of 1422 companies
Payout #180 of 1422 companies
Safety #464 of 1422 companies
Price #1161 of 1422 companies